Midatech has announced an extension of the Q-Sphera R&D Collaboration (‘the Collaboration’) that was originally detailed on 21 July 2020, while also disclosing that the previously unnamed party is, in
Midatech has announced an extension of the Q-Sphera R&D Collaboration (‘the Collaboration’) that was originally detailed on 21 July 2020, while also disclosing that the previously unnamed party is, in
Breakthrough data on the successful encapsulation of a biologic using Q-Sphera technology Significant progress across multiple other R&D programmes
Midatech yesterday published a business update which included a number of elements of positive news. These included:
Phase II Dose Confirmed and Encouraging Survival Data
Midatech has today announced encouraging headline results from a Phase I study at the University of California, San Francisco (‘UCSF’) in patients with the orphan condition, Diffuse Intrinsic Pontine Glioma
Midatech has today announced its signing of further research collaboration, this time with an unnamed ‘global pharmaceutical’ group that wishes to utilise its Q-Sphera™ platform in order to improve/optimise the
Midatech Pharma’s next generation drug delivery technologies to be applied to new modalities in collaboration with a European pharmaceutical company.
Moving from rule based systems into Machine Learning by Aleksander Kijek (Nethone) at TECH Conference Europe 2019 (TCE2019)
Capt.L.C. Arrigo GARIPOLI, Founder at BlueQbit to speak at PICANTE TECH Conference Europe 2019 (TCE2019)
Capt.L.C. Arrigo GARIPOLI, Founder at BlueQbit to speak at PICANTE TECH Conference Europe 2019 (TCE2019)
We are excited to present a fresh new press release featuring Dr. Jean Paul Fabri on the fact that investment in fintech companies in Europe alone reached €23 billion. More